Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol Dosage in Turner Syndrome
NCT00134745Phase 4Completed
- Start
- Jun 2005
- Primary completion
- Mar 2013
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of estradiol in Turner syndrome (TS) (2 arms). Primary endpoints: The size of the uterus evaluated by magnetic resonance (MR)-scan at 5 years and Bones evaluated by dual-energy X-ray absorptiometry (DEXA)-scan at 5 years. Started Jun 2005; status: completed.
02
Drugs
estradiol
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NCT00134745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134745.